Rizatriptan

CHEMBL905 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
269.3 g/mol
LogP
1.7
Phase
4

A triptan medication used to treat acute migraine attacks, with or without aura, by constricting dilated blood vessels and blocking pain signals in the brain. It works within 30 minutes for most patients and is available in both regular tablets and orally disintegrating formulations.

น้ำหนักโมเลกุล

269.3400 g/mol

LogP

1.70

TPSA

49.70 Ų

Lipinski RO5

ผ่าน

ด้านการรักษา

Pharmacokinetics (PK)

Pharmacodynamics (PD)

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12

InChI

InChI=1S/C15H19N5/c1-19(2)6-5-13-8-17-15-4-3-12(7-14(13)15)9-20-11-16-10-18-20/h3-4,7-8,10-11,17H,5-6,9H2,1-2H3

Molecular Formula

C15H19N5

HBD / HBA

1 / 3

พันธะที่หมุนได้

5

อะตอมหนัก

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

A triptan medication used to treat acute migraine attacks, with or without aura, by constricting dilated blood vessels and blocking pain signals in the brain. It works within 30 minutes for most patients and is available in both regular tablets and orally disintegrating formulations.

Yes, Rizatriptan is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL905. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5078. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.